Table 7 Change in HbA1c as reported in the evidence review by Martin et al.
Intervention | Comparator | Mean difference (IV, random, 95% CI) |
|---|---|---|
NPH | Degludec-U100 | −0.08 (−0.05, 0.22) |
Glargine-U100 | Degludec-U100 | 0.00 (−0.11, 0.10) |
Detemir | Degludec-U100 | −0.01 (−0.14, 0.12) |
NPH | Glargine-U300 | −0.02 (−0.19, 0.24) |
Glargine-U100 | Glargine-U300 | −0.06 (−0.25, 0.13) |
Detemir | Glargine-U300 | −0.07 (−0.29, 0.16) |